Nino Müser

196eP Real-world treatment patterns and sequencing of ALK inhibitors in ALK-positive NSCLC treated with palliative intent

Leyla Ay, Julie Krainer, A.S. Lang-Stöberl, Hannah Fabikan et autres

at, de (code pays fourni par la source)

Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study

Caroline Braschel, Hannah Fabikan, Vania Mikaela Rodriguez, Maximilian J. Hochmair et autres

at, de (code pays fourni par la source)

Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study

Caroline Braschel, Hannah Fabikan, Maximilian J. Hochmair, Oliver Illini et autres

at, de (code pays fourni par la source)

2767P Patients with extensive stage small-cell lung cancer (ES-SCLC) and poor performance status receiving atezolizumab-carboplatin-etoposide (SPACE): A single-arm phase II AIO study (AIO-TRK-0119)

M. Sebastian, J.A. Stratmann, P. Sadjadian, Charis Faoro et autres

de, at (code pays fourni par la source)

The Efficacy of First-Line Pembrolizumab Monotherapy in Patients with Metastatic NSCLC Aged ≥70 Years with High PD-L1 (TPS ≥ 50%) Expression: A Multicenter Real-World Study

Filip Marković, Maximilian J. Hochmair, Nino Müser, Hannah Fabikan et autres

at, si, rs (code pays fourni par la source)

The efficacy of first-line pembrolizumab monotherapy in patients with metastatic NSCLC aged ≥70 years with high PD-L1 (TPS ≥50%) expression

Filip Marković, Maximilian J. Hochmair, Nino Müser, Hannah Fabikan et autres

Comparison of whole-body 18F-FDG-PET/CT with 18F-FDG-PET/CT limited to skull base to upper abdomen for primary staging of lung cancer – a retrospective explorative analysis

Lukas Schulz, Georg‐Christian Funk, Klaus Kirchbacher, Nino Müser et autres

at (code pays fourni par la source)

Real-world NGS testing results and treatment modalities in lung cancer: Data update from LALUCA - Landsteiner Lung Cancer Research Platform

Anna Sophie Lang-Stöberl, David Rosenthaler, Hannah Fabikan, Christoph Weinlinger et autres

de, at (code pays fourni par la source)

Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study

Maximilian J. Hochmair, Angelika Terbuch, David Lang, Christian Trockenbacher et autres

at (code pays fourni par la source)

The Landsteiner lung cancer research platform (LALUCA)

Anna Sophie Lang-Stöberl, Hannah Fabikan, Maximilian J. Hochmair, Klaus Kirchbacher et autres

at (code pays fourni par la source)

Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report

Nino Müser, Klaus Kirchbacher, Georg‐Christian Funk

at (code pays fourni par la source)

High mortality in patients with active malignancy and severe COVID-19

Simon Udovica, Nino Müser, Agnes Pechlaner, Andreas Reichinger et autres

at (code pays fourni par la source)